- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
MDeverywhere alliance points PDA apps at physician groups
MDeverywhere alliance points PDA apps at physician groupsMDeverywhere, a provider of mobile computing applications, has formed a strategic alliance with Beacon Partners, a national healthcare-management consulting firm, to make
MDeverywhere alliance points PDA apps at physician groups
MDeverywhere, a provider of mobile computing applications, has formed a strategic alliance with Beacon Partners, a national healthcare-management consulting firm, to make MDeverywheres EveryCharge application available to multiple-physician group practices. EveryCharge allows physicians to capture diagnoses, treatment, and other billing information on a handheld device; other services, including dictation, order entry, and prescriptions, will be integrated over the next few months. The two firms have already identified several large physician group practices to market this service to, and they expect the first customers to go live by October.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
